←back to thread

126 points julianh65 | 7 comments | | HN request time: 1.229s | source | bottom
1. phoronixrly ◴[] No.44444775[source]
The suggestion/allusion that the EU's GDP per capita is lower than the US due to Adderall and Dexedrine not being approved/available is wild. Kind of makes me not want to take seriously the rest of the article...
replies(4): >>44444982 #>>44445165 #>>44446175 #>>44448319 #
2. stevenAthompson ◴[] No.44444982[source]
I'm not even certain it's fair to refer to these things (or modafinil) as nootropics, as nootropics (as defined by the person who coined the phrase) should lack stimulate/sedative properties.
3. y-curious ◴[] No.44445165[source]
Data is well presented but the conclusions are iffy. But hey, maybe Europe can stop limiting its own industry with regulation if they just up that dextroamphetamine dose?
4. jackdeansmith ◴[] No.44446175[source]
I think this is clearly a joke
replies(1): >>44448038 #
5. phoronixrly ◴[] No.44448038[source]
Sure hope so.
6. blitzar ◴[] No.44448319[source]
Adderall is a performance enhancing drug, and widly used as such. Its nigh on impossible to compete at the highest level workplaces with doped employees if you are a natural worker.
replies(1): >>44449174 #
7. phoronixrly ◴[] No.44449174[source]
The graph implies is that aderall causes people to perform at 150% on average if 100% of the workforce is on it. I say that both implying that aderall has such a massive objective effect and implying it is so widely (ab)used are the laughable ramblings of a psychonaut at worst and unsubstantiated at best.